In addition to the potential targets like the MAPK-14 inhibitors and FOS, we conducted the protein-drug interaction analysis of the shared DEGs between COVID-19 and the neurological diseases, identifying the candidate COVID-19 therapies. Here, FOS is linked to COVID-19.